A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces

被引:0
|
作者
Chen, Jun [1 ]
Yang, Jingwen [1 ]
Shen, Dayong [1 ]
Wang, Xi [1 ]
Lin, Zihao [1 ]
Chen, Hao [1 ]
Cui, Guiyun [1 ]
Zhang, Zuohui [1 ,2 ]
机构
[1] Xuzhou Med Univ, Affiliated Hosp, Dept Neurol, Xuzhou 221006, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu 22106, Peoples R China
基金
加拿大健康研究院;
关键词
Alzheimer's disease; mild cognitive impairment; nomogram; perivascular space; SMALL-VESSEL DISEASE; BIOMARKERS; RISK; MCI;
D O I
10.3233/JAD-240523
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Mild cognitive impairment (MCI) is a heterogeneous condition that can precede various forms of dementia, including Alzheimer's disease (AD). Identifying MCI subjects who are at high risk of progressing to AD is of major clinical relevance. Enlarged perivascular spaces (EPVS) on MRI are linked to cognitive decline, but their predictive value for MCI to AD progression is unclear. Objective: This study aims to assess the predictive value of EPVS for MCI to AD progression and develop a predictive model combining EPVS grading with clinical and laboratory data to estimate conversion risk. Methods: We analyzed 358 patients with MCI from the ADNI database, consisting of 177 MCI-AD converters and 181 non-converters. The data collected included demographic information, imaging data (including perivascular spaces grade), clinical assessments, and laboratory test results. Variable selection was conducted using the Least Absolute Shrinkage and Selection Operator (LASSO) method, followed by logistic regression to develop predictive model. Results: In the univariate logistic regression analysis, both moderate (OR = 5.54, 95% CI [3.04-10.18]) and severe (OR =25.04, 95% CI [10.07-62.23]) enlargements of the centrum semiovale perivascular space (CSO-PVS) were found to be strong predictors of disease progression. LASSO analyses yielded 12 variables, refined to six in the final model: APOE4 genotype, ADAS11 score, CSO-PVS grade, and volumes of entorhinal, fusiform, and midtemporal regions, with an AUC of 0.956 in the training and 0.912 in the validation cohort. Conclusions: Our predictive model, emphasizing EPVS assessment, provides clinicians with a practical tool for early detection and management of AD risk in MCI patients.
引用
收藏
页码:159 / 173
页数:15
相关论文
共 50 条
  • [1] Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer's disease: A 7 Tesla MRI study
    Bouvy, Willem H.
    van Veluw, Susanne J.
    Kuijf, Hugo J.
    Zwanenburg, Jaco J. M.
    Kappelle, Jaap L.
    Luijten, Peter R.
    Koek, Huiberdina L.
    Geerlings, Mirjam, I
    Biessels, Geert J.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (04) : 739 - 746
  • [2] Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease
    Gabriel, Antonio Jose
    Almeida, Maria Rosario
    Ribeiro, Maria Helena
    Carneiro, Diogo
    Valerio, Daniela
    Pinheiro, Ana Cristina
    Pascoal, Rui
    Santana, Isabel
    Baldeiras, Ines
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (03) : 1097 - 1105
  • [3] Combinatorial Markers of Mild Cognitive Impairment Conversion to Alzheimer's Disease - Cytokines and MRI Measures Together Predict Disease Progression
    Furney, Simon J.
    Kronenberg, Deborah
    Simmons, Andrew
    Guentert, Andreas
    Dobson, Richard J.
    Proitsi, Petroula
    Wahlund, Lars Olof
    Kloszewska, Iwona
    Mecocci, Patrizia
    Soininen, Hilkka
    Tsolaki, Magda
    Vellas, Bruno
    Spenger, Christian
    Lovestone, Simon
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 : 395 - 405
  • [4] Oxidative Damage and Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment
    Baldeiras, Ines
    Santana, Isabel
    Proenca, Maria Teresa
    Garrucho, Maria Helena
    Pascoal, Rui
    Rodrigues, Ana
    Duro, Diana
    Oliveira, Catarina Resende
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1165 - 1177
  • [5] Mild cognitive impairment and progression to dementia of Alzheimer's disease
    Quintes Steiner, Ana Beatriz
    Jacinto, Alessandro Ferrari
    De Sa Mayoral, Vania Ferreira
    Dozzi Brucki, Sonia Maria
    Citero, Vanessa De Albuquerque
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 651 - 655
  • [6] Prediction of the progression from mild cognitive impairment to Alzheimer's disease using a radiomics-integrated model
    Shu, Zhen-Yu
    Mao, De-Wang
    Xu, Yu-Yun
    Shao, Yuan
    Pang, Pei-Pei
    Gong, Xiang-Yang
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [7] Assessment of enlarged perivascular spaces and their relation to target organ damage and mild cognitive impairment in patients with hypertension
    Riba-Llena, I.
    Nafria, C.
    Mundet, X.
    Lopez-Rueda, A.
    Fernandez-Cortinas, I.
    Jarca, C. I.
    Jimenez-Balado, J.
    Domingo, M.
    Tovar, J. L.
    Orfila, F.
    Pujadas, F.
    Alvarez-Sabin, J.
    Maisterra, O.
    Montaner, J.
    Delgado, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (06) : 1044 - 1050
  • [8] Investigating predictors of progression from mild cognitive impairment to Alzheimer's disease based on different time intervals
    Wu, Yafei
    Wang, Xing
    Gu, Chenming
    Zhu, Junmin
    Fang, Ya
    AGE AND AGEING, 2023, 52 (09)
  • [9] Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease
    Ouma, Shinji
    Suenaga, Midori
    Hatip, Funda F. Bolukbasi
    Hatip-Al-Khatib, Izzettin
    Tsuboi, Yoshio
    Matsunaga, Yoichi
    BRAIN AND BEHAVIOR, 2018, 8 (03):
  • [10] MRI Visible Perivascular Spaces and the Risk of Incident Mild Cognitive Impairment in a Community Sample
    Pase, Matthew P.
    Pinheiro, Adlin
    Rowsthorn, Ella
    Demissie, Serkalem
    Hurmez, Saoresho
    Aparicio, Hugo J.
    Rodriguez-Lara, Frances
    Gonzales, Mitzi M.
    Beiser, Alexa
    DeCarli, Charles
    Seshadri, Sudha
    Romero, Jose Rafael
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 96 (01) : 103 - 112